Product Name :
Anti-TNFSF13B/CD257(Belimumab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human TNFSF13B/CD257/BAFF
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-TNFSF13B/CD257(Belimumab Biosimilar) Antibody is a biosimilar antibody directed against Human TNFSF13B/CD257/BAFF.{{315704-66-6} web|{315704-66-6} Technical Information|{315704-66-6} Data Sheet|{315704-66-6} supplier} | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: Human TNFSF13B/CD257/BAFF | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-TNFSF13B/CD257(Belimumab Biosimilar) Antibody is a biosimilar antibody directed against Human TNFSF13B/CD257/BAFF.{{52557-26-3} medchemexpress|{52557-26-3} Purity & Documentation|{52557-26-3} In stock|{52557-26-3} supplier}
Immunogen:
Host :
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.PMID:25905188 Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically.